News

US judge denies injunction, restricts copies of weight-loss drug Ozempic
A US judge on Thursday rejected a bid by compounding pharmacies to keep making copies of Novo Nordisk's popular diabetes and ...
FDA stops sale of generic versions of Ozempic and Wegovy: What to do if you’re taking them
Many compounding pharmacies are no longer allowed to make cheaper versions of semaglutide and other GLP-1 drugs. A doctor ...
Prediction: Eli Lilly's Newest GLP-1 Drug Will Be a Game-Changer for the Stock
Let's look at why this news could be a game-changer for Eli Lilly and its stock.
ABC7 KABC13d
Tirzepatide, also known as Mounjaro or Zepbound, may help treat sleep apnea
You may know about tirzepatide, also known as Mounjaro or Zepbound, due to its popularity for those looking to lose weight or treat diabetes. Now, researchers have gotten it approved to treat sleep ...
Analysts Maintain Buy Ratings on Eli Lilly Stock (LLY) as Q1 Earnings Loom
Eli Lilly (LLY) is scheduled to release its Q1 earnings on May 1, and analysts continue to stay positive, holding onto Buy ratings for the ...
Eli Lilly sues telehealth companies selling compounded Zepbound, Mounjaro
Eli Lilly is suing four telemedicine companies selling compounded versions of its blockbuster obesity drug Zepbound and its ...
North Penn Now3d
Alternatives to Compounded Semaglutide & Tirzepatide: Affordable & Effective Options for Patients In The USA
"With the FDA announcing the resolution of shortages for Semaglutide (Wegovy, Ozempic) and Tirzepatide (Zepbound, Mounjaro), compounding pharmacies must halt production of these medications. This ...